---
title: "oncolytic Virus Immunotherapy for Glioblastoma: Mechanisms and Clinical Potential"
summary: Affiliated with Purdue University Honors College
date: "2016-04-27"

# Optional external URL for project (replaces project detail page).
external_link: 

image:
  caption: Photo by Toa Heftiba on Unsplash
  focal_point: Smart
---
Conducted a literature review on oncolytic viruses (OVs) as an emerging immunotherapy for glioblastoma (GBM), focusing on how engineered viruses selectively lyse tumor cells and stimulate anti-tumor immune responses. Analyzed key platforms such as adenovirus (DNX-2401) and HSV-based vectors, clinical trial outcomes, and major translational challenges including bloodâ€“brain barrier delivery, tumor immunosuppression, and viral neutralization. Also examined combination strategies with radiation and immune checkpoint inhibitors, highlighting the potential of viro-immunotherapy to overcome therapeutic resistance in aggressive solid tumors.

**Skills : Literature Review**